Mayo Clinic Archives

Mayo Clinic

The DECIPHER Marker Can Predict Chemotherapy

Posted by Alan H. Bryce, MD | Jan 2018

Alan H. Bryce, MD makes the pro side of the argument that the DECIPHER marker is an effective tool for predicting a patient’s response to chemotherapy. He also summarizes the ongoing trials and research regarding this specific biomarker. This is a counter argument to Robert Abouassaly’s lecture, “Can The DECIPHER Marker Can Predict Chemotherapy?”

BCG Maintenance – Full SWOG Course – Pro Argument

Posted by Erik P. Castle, MD, FACS | Jan 2018

Erik P. Castle, MD, explains the Southwest Oncology Group’s (SWOG’s) protocol for administering maintenance doses of bacillus Calmette-Guerin (BCG) to non-muscle invasive bladder cancer patients. He argues that carrying out the full SWOG course makes a positive impact on patients’ recurrence free survival rates, identifying the ideal disease types and patients to receive the full course.